Matches in Nanopublications for { ?s ?p "DDI between Bicalutamide and Budesonide - CYP3A4 Inhibitors like bicalutamide may increase the serum concentration of budesonide. The clinical significance of this interaction is greater for oral budesonide than for orally inhaled budesonide. Consider reducing the oral budesonide dose when used together with a CYP3A4 inhibitor. [drugbank_resource:DB01128_DB01222]"@en ?g. }
Showing items 1 to 1 of
1
with 100 items per page.
- drugbank_resource:DB01128_DB01222 label "DDI between Bicalutamide and Budesonide - CYP3A4 Inhibitors like bicalutamide may increase the serum concentration of budesonide. The clinical significance of this interaction is greater for oral budesonide than for orally inhaled budesonide. Consider reducing the oral budesonide dose when used together with a CYP3A4 inhibitor. [drugbank_resource:DB01128_DB01222]" assertion.